| Literature DB >> 33966364 |
Karuna Wongtangman1, Sirichai Wilartratsami2, Nattachai Hemtanon1, Supinya Tiviraj1, Manee Raksakietisak1.
Abstract
STUDYEntities:
Keywords: Fluid therapy; Goal-directed therapy; Hypotension; Laminectomy; Prone
Year: 2021 PMID: 33966364 PMCID: PMC9260406 DOI: 10.31616/asj.2020.0597
Source DB: PubMed Journal: Asian Spine J ISSN: 1976-1902
Fig. 1Goal-directed fluid therapy protocol. Acceptable PPV=13+% change in static lung compliance after prone position; hypotension: MAP decrease more than 25% of preoperative MAP value. Preoperative: the day before surgery (400 mL of 12.5% carbohydrate drinks after 6 PM until the bedtime; on the day of surgery (200 mL of glucose solution per oral; acetate Ringer’s solution IV rate 100 mL/hr since 7 AM); intraoperative: give acetate Ringer’s solution 200 mL IV within 10 minutes (can repeat up to 3 times or 10 mL/kg) to keep PPV <13% before turn to prone position. PPV, pulse-pressure variation; BP, blood pressure; Hct, hematocrit; SBP, systolic blood pressure; MAP, mean arterial pressure; HR, heart rate; EBL, estimated blood loss; Bl vol, blood volume; IV, intravenous; PRC, packed red cells.
Fig. 2Consort diagram of the study. eGFR, estimated glomerular filtration rate; BMI, body mass index; GDT, goal-directed therapy.
Patient demographic data
| Characteristic | Control (n=30) | GDT (n=27) | |
|---|---|---|---|
| Age (yr) | 60.80±7.78 | 56.19±13.02 | 0.117 |
| Sex | 0.153 | ||
| Male | 11 | 15 | |
| Female | 19 | 12 | |
| Height (cm) | 159.17±9.07 | 162.41±8.91 | 0.167 |
| Weight (kg) | 60.11±9.08 | 65.20±9.96 | 0.049 |
| Body mass index (kg/m2) | 23.76±3.23 | 24.72±3.38 | 0.276 |
| ASA classification 1/2/3 | 10/18/2 | 10/16/1 | 0.657 |
| Comorbidity | |||
| Diabetes | 6 (20.0) | 3 (11.1) | 0.476 |
| Hypertension | 12 (40.0) | 12 (44.4) | 0.734 |
| Dyslipidemia | 7 (23.3) | 8 (29.6) | 0.590 |
| Preoperative MAP (mm Hg) | 89±12 | 94±10 | 0.131 |
| Creatinine (mg/dL) | 0.77±0.17 | 0.82±0.23 | 0.357 |
| eGFR (mL/min/1.73 m2) | 88.57±14.48 | 92.16±18.28 | 0.413 |
| Hematocrit (%) | 39.03±4.19 | 40.22±4.75 | 0.322 |
Values are presented as mean±standard deviation, number, or number (%).
GDT, goal-directed therapy; ASA, American Society of Anesthesiologists; MAP, mean arterial blood pressure; eGFR, estimated glomerular filtration rate.
Intraoperative data
| Characteristic | Control (n=30) | GDT (n=27) | |
|---|---|---|---|
| Type of surgery | 0.896 | ||
| Laminectomy | 1 (3.3) | 1 (3.7) | |
| 1–3 level instrumentation | 15 (50.0) | 11 (40.7) | |
| ≥4 level instrumentation | 11 (36.7) | 11 (40.7) | |
| Laminectomy with tumor removal | 3 (10.0) | 4 (14.8) | |
| Duration of surgery (min) | 236.67±96.54 | 220.37±73.22 | 0.480 |
| Blood loss (mL) | 575 (250–900) | 500 (325–800) | 0.892 |
| Intraoperative fluid | |||
| Crystalloid (mL) | 1,900 (1,200–2,800) | 2,000 (1,425–2,700) | 0.904 |
| Colloid (mL) | 0 (0–0) | 0 (0–500) | 0.107 |
| Packed red cells (unit) | 0 (0–1) | 0 (0–0) | 0.452 |
| Hypotension | |||
| Incidence | 24 (80.0) | 18 (66.6) | 0.250 |
| Episodes | 2 (1–3) | 1 (0–3) | 0.568 |
| After induction | 16 (53.3) | 9 (33.3) | 0.129 |
| After prone | 7 (23.3) | 4 (14.8) | 0.416 |
| Medical treatment | 14 (46.7) | 15 (55.6) | 0.503 |
| Ephedrine (mg) | 0 (0–12) | 6 (0–9) | 0.642 |
| Urine output (mL/kg/hr) | 1.25±0.76 | 1.38±0.99 | 0.574 |
| Intraoperative oliguric episode | 0 (0–1) | 0 (0–1) | 0.424 |
Values are presented as number (%), mean±standard deviation, or median (interquartile range).
GDT, goal-directed therapy.
Postoperative data
| Outcome measure | Control (n=30) | GDT (n=27) | |
|---|---|---|---|
| Length of hospital stay (day) | 9.5 (8.0–15.0) | 9.0 (7.5–10.5) | 0.223 |
| Unplanned intensive care unit admission | 2 (6.7) | 0 | 0.492 |
| Renal complications | 18 (60) | 14 (51.9) | 0.536 |
| Oliguria (hr) | 2 (0–4) | 1 (0–2) | 0.263 |
| Creatinine rising (times) | 0.96 (0.86–1.07) | 0.96 (0.92–1.05) | 0.719 |
| Respiratory complication | 2 (6.7) | 0 | 0.492 |
| Cardiovascular complication | 0.708 | ||
| Episodes of hypotension | 1.5 (1.0–4.0) | 1.0 (0.0–3.0) | |
| Cardiac arrhythmia | 0 | 0 | |
| Suspected myocardial infarction | 0 | 0 | |
| Neurological complication | 0.490 | ||
| Stroke | 0 | 0 | |
| Postoperative delirium | 2 (6.7) | 0 | |
| New onset of weakness or numbness | 0 | 0 | |
| Bowel ileus | 23 (76.7) | 16 (61.5) | 0.219 |
Values are presented as median (interquartile range) or number (%).
GDT, goal-directed therapy.
Outcome of intraoperative hypotension
| Outcome measure | Intraoperative hypotension | ||
|---|---|---|---|
| Yes (n=42) | No (n=15) | ||
| Length of hospital stay (day) | 9.0 (8.0–12.0) | 9 (7.0–10.0) | 0.131 |
| Renal complications | 24 (57.1) | 8 (53.3) | 0.517 |
| Postoperative hypotension | 5 (11.9) | 0 | 0.310 |
| Postoperative delirium | 2 (4.8) | 0 | 0.539 |
| Stool pass (day) | 4 (3.0–5.0) | 2 (1.0–3.0) | 0.005 |
Values are presented as median (interquartile range) or number (%). Renal complications were defined as oliguria (a urine output of <0.5 mL/kg/hr×12 hours) or rising creatinine×2 compared with baseline.
p<0.05; statistically significant.